FEDERAL COURT OF AUSTRALIA
Jele Chemists Pty Ltd v Australian Community Pharmacy Authority [2025] FCAFC 54
Appeal from: Jele Chemists Pty Ltd v Australian Community Pharmacy Authority [2023] FCA 1652 File number: QUD 47 of 2024 Judgment of: COLLIER ACJ, ROFE AND HORAN JJ Date of judgment: 15 April 2025 Catchwords: ADMINISTRATIVE LAW – proper construction of s 10(3)(c) of National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (Cth) (National Health Rules) – whether development approval under Planning Act 2016 (Qld) is required to be in effect for Australian Community Pharmacy Authority (ACPA) to make recommendation to Secretary of Department of Health and Aged Care (Secretary) – whether ACPA required to engage with local government and State or Territory planning laws – whether institution of appeal of development approval means premises unable to be used for operation of pharmacy “at all relevant times” – whether recommendation of ACPA only possible in relation to physical premises – whether “proposed premises” means physical premises – whether measurement between two premises requires existence of two physical premises – s 8 and sch 1, pt 2, item 130 of National Health Rules – appeal dismissed Legislation: Administrative Decisions (Judicial Review) Act 1977 (Cth) ss 5(1)(f), 5(1)(h)
Judiciary Act 1903 (Cth) s 79
National Health Act 1953 (Cth) ss 90, 99K, 99L, 99N
National Health (Australian Community Pharmacy Authority Rules) Determination 2018 (Cth) ss 5, 8(1), 10(1)(b)(ii), 10(2)(b)(ii), 10(3)(c), sch 1, pt 2, item 130
Integrated Planning Act 1997 (Qld) s 3.5.19
Planning Act 2016 (Qld) s 71
Cases cited: Assarapin v Australian Community Pharmacy Authority (2016) 239 FCR 161; [2016] FCAFC 9
Graham v Minister for Immigration and Border Protection (2017) 263 CLR 1
Hayes v Walker (2004) 134 LGERA 290; [2004] QCA 288
Hossain v Minister for Immigration and Border Protection (2018) 264 CLR 123
Jele Chemists Pty Ltd v Australian Community Pharmacy Authority [2023] FCA 1652
R v Connell; Ex parte Hetton Bellbird Collieries Ltd (1944) 69 CLR 407
Shrestha v Minister for Immigration and Border Protection (2018) 264 CLR 151
Te v Minister for Immigration and Ethnic Affairs (1999) 88 FCR 264
Terry White Chemists Australia Fair v Secretary to the Department of Health and Ageing (2009) 178 FCR 161; [2009] FCAFC 74
Watson v Australian Community Pharmacy Authority (2012) 206 FCR 365
Division: General Division Registry: Queensland National Practice Area: Administrative and Constitutional Law and Human Rights Number of paragraphs: 72 Date of hearing: 21 August 2024 Counsel for the Appellant: Mr C Gunson SC with Dr A McBeth Solicitor for the Appellant: Robert James Lawyers Counsel for the First Respondent: Ms K E Slack Solicitor for the First Respondent: Sparke Helmore Lawyers Counsel for the Second Respondent: The Second Respondent filed a submitting notice, save as to costs Counsel for the Third Respondent: Mr T Flaherty Solicitor for the Third Respondent: Michael Flaherty Solicitor ORDERS
QUD 47 of 2024 BETWEEN: JELE CHEMISTS PTY LTD (ACN 651 116 666)
Appellant
AND:
Keep reading for free
Create a free CaseChat account to read Jele Chemists Pty Ltd v Australian Community Pharmacy Author... and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2025] FCAFC 54
- Decision Date
CaseChat Overview and Summary
The court's reasoning focused on the proper construction of the relevant provisions of the National Health Rules and the legislative framework governing pharmacy approvals. The primary Judge had correctly interpreted the provisions, and the Full Court found no error in her Honour's reasoning. The court held that there was no requirement for final development approval to be in effect before the Authority could make a recommendation. The court also clarified that compliance with relevant local government and State or Territory planning laws was a factor for consideration, but not an absolute requirement. The court found that the primary Judge's interpretation of the provisions was consistent with the object of the legislation, which was to establish and regulate the provision of drugs and medicinal preparations on a subsidised basis. The court further held that the Secretary was not required to engage in an onerous procedure involving duplication of functions by considering every provision of State or Territory law that might bear on the legality of conducting a pharmacy business.
The appeal was dismissed, and the appellant was ordered to pay the costs of the third respondent of and incidental to the appeal, to be taxed if not otherwise agreed. This outcome upheld the primary Judge's decision and affirmed the correct interpretation and application of the relevant provisions in the National Health Rules and the Planning Act.
Orders
Orders of the court
1. The appeal be dismissed.
2. The appellant pay the costs of the third respondent of and incidental to the appeal, to be taxed if not otherwise agreed.
Note: Entry of orders is dealt with in Rule 39.32 of the Federal Court Rules 2011.
Background
Background to the litigation
Evidence
Evidence Before The Court
Decision
Reasons for decision
Ratio Decidendi
Legal Principle Established
Established by: COLLIER ACJ
In relation to ground of appeal 2, the third respondent further submitted, in summary that:·The use of the modifier “proposed” with respect to premises indicates that premises can be under construction or planned to be built, provided that their proposed location is readily ascertainable.·In any event, proposed premises, whether unbuilt, partially constructed or built could not “lawfully be used” as a pharmacy without full and final development approval, as well as having been stocked, fitted out and obtained the approval of the relevant State pharmacy bodies.CONSIDERATION We have already set out in some detail relevant legislative provisions, and the primary Judge’s reasons for judgment interpreting those provisions. Importantly, for the purposes of this appeal, pursuant to s 90 of the National Health Act (where a pharmacist applies for approval to supply pharmaceutical benefits from particular premises) the Secretary must refer the application to ACPA. In considering an application referred to it by the Secretary, ACPA must comply with the National Health Rules: s 99K of the National Health Act. The Secretary may only approve an application if ACPA has recommended the application for approval: s 90(3B) of the National Health Act. In our view, the primary Judge correctly construed the provisions of the National Health Act and the National Health Rules. Her Honour’s decision should be upheld. We have formed this view for the following reasons. First, as the primary Judge correctly found, there is no requirement that a final development approval for the operation of a pharmacy at the proposed premises be in effect before ACPA can make a recommendation for approval by the Secretary. Section 10(3)(c) of the National Health Rules plainly provides that a recommendation can be made if (inter alia) at all relevant times a proposed premises could be used for the operation of a pharmacy under applicable planning laws. In the present case, as ACPA noted in its decision, a Development Application Decision Notice dated 1 April 2022 was issued by the Toowoomba Regional Council approving the Material Change of Use of the proposed premises to “Health Care Service and Shop”. As the primary Judge further observed, the Note to s 10(3) of the National Health Rules makes clear that final effective development approval is unnecessary. In particular, reference should be made to the statement in the Note that s 10(3)(c) would be satisfied if “the proposed premises are on land that is zoned so as to enable the operation of a pharmacy”. The interpretation of s 10(3)(c) applied by the primary Judge is consistent with earlier authority. It is not in doubt that compliance with relevant local government and State or Territory planning laws is a factor for consideration, by both ACPA and ultimately the Secretary, in respect of pharmacy approvals. However, as the Full Court observed in Terry White Chemists in respect of an earlier (but comparable) iteration of s 90(1) of the National Health Act, the object of the legislation in respect of applications for approval to conduct the operation of a pharmacy at proposed premises:19.…is to establish and regulate the provision of drugs and medicinal preparations to members of the public for whom they are prescribed, on a subsidised basis. It is unlikely that, in the pursuit of a purpose associated with that scheme, Parliament would have intended to require the Secretary to search for and consider every provision of the law of the State or Territory in which the relevant premises were situated that might bear on the legality of the person applying for approval conducting the business of a pharmacist at those premises. Not only would the task of ascertaining what were the relevant provisions be onerous, the process of applying them would involve duplication of functions that are already committed to the authorities of the State or Territory concerned. It is unlikely that Parliament intended that such duplication should occur. The rights and wrongs of the conduct of particular activities at particular premises are matters for the concern of State and Territory authorities, and not for the concern of the Secretary. A construction that requires the Secretary to engage in an onerous procedure, involving duplication of functions, should not be adopted if there is an alternative construction that promotes the purpose or object of the provisions. To the extent to which it might be considered that State or Territory laws are relevant, it is open to the Minister to make rules pursuant to s 99L of the National Health Act, requiring the Authority to apply those laws as part of its consideration of an application for approval referred to it under s 90(3A) of the National Health Act.(emphasis added)